Advisory Research Inc Guardant Health, Inc. Transaction History

Advisory Research Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $422,044 - $564,762	-4,273 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $56,202 - $84,828	-512 Reduced 10.7%	4,273 $531,000
Q1 2021 May 12, 2021	SELL	$127.04 - $179.1 $585,654 - $825,651	-4,610 Reduced 49.07%	4,785 $730,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $164,134 - $223,197	-1,642 Reduced 14.88%	9,395 $1.21 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $209,956 - $292,245	2,614 Added 31.03%	11,037 $1.23 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $123,278 - $198,705	2,038 Added 31.92%	8,423 $683,000
Q1 2020 May 12, 2020	SELL	$59.04 - $88.81 $524,393 - $788,810	-8,882 Reduced 58.18%	6,385 $444,000
Q4 2019 Feb 11, 2020	SELL	$59.49 - $82.78 $365,804 - $509,014	-6,149 Reduced 28.71%	15,267 $1.19 Million
Q3 2019 Nov 12, 2019	SELL	$62.59 - $110.3 $457,345 - $805,962	-7,307 Reduced 25.44%	21,416 $1.37 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $489,013 - $696,809	7,648 Added 36.29%	28,723 $2.48 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $161,724 - $461,975	4,715 Added 28.82%	21,075 $1.62 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $477,712 - $754,196	16,360 New	16,360 $615,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.